Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVB
3551
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $292K | ﹤0.01% |
+22,744
| New | +$287K |
|
3552
Tilly's
TLYS
$122M
| $291K | ﹤0.01% |
48,243
+28,393
| +143% | +$179K |
|
|
TARO
3553
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $291K | ﹤0.01% |
5,300
-2,800
| -35% | -$174K |
|
3554
i3 Verticals
IIIV
$319M
| $290K | ﹤0.01% |
11,500
-13,117
| -53% | -$351K |
|
|
FIT
3555
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $290K | ﹤0.01% |
41,700
| – | – |
|
3556
Codexis
CDXS
$171M
| $289K | ﹤0.01% |
24,600
-4,892
| -17% | -$60.9K |
|
3557
PUT
J.M. Smucker
SJM
$13B
| $289K | ﹤0.01% |
2,500
| – | – |
|
3558
PUT
Stratasys
SSYS
$781M
| $289K | ﹤0.01% |
23,200
-2,700
| -10% | -$39.4K |
|
|
NUAN
3559
CALL
DELISTED
Nuance Communications, Inc.
NUAN
| $289K | ﹤0.01% |
8,700
-4,000
| -31% | -$116K |
|
3560
PUT
The Mosaic Company
MOS
$6.87B
| $287K | ﹤0.01% |
15,700
-6,700
| -30% | -$109K |
|
3561
Seneca Foods Class A
SENEA
$1.3B
| $287K | ﹤0.01% |
8,039
+1,773
| +28% | +$71.5K |
|
3562
Cue Biopharma
CUE
$144M
| $286K | ﹤0.01% |
634
+116
| +22% | +$66.8K |
|
3563
Greenlight Captial
GLRE
$514M
| $285K | ﹤0.01% |
42,297
-7,799
| -16% | -$53.6K |
|
3564
Webster Financial
WBS
$12.8B
| $285K | ﹤0.01% |
10,766
+619
| +6% | +$16.8K |
|
|
BHR
3565
Braemar Hotels & Resorts
BHR
$139M
| $284K | ﹤0.01% |
113,557
-30,694
| -21% | -$77.8K |
|
3566
CALL
Iron Mountain
IRM
$38.5B
| $284K | ﹤0.01% |
10,600
-4,300
| -29% | -$122K |
|
3567
CALL
Plug Power
PLUG
$3.24B
| $284K | ﹤0.01% |
+21,200
| New | +$234K |
|
3568
Protagonist Therapeutics
PTGX
$10B
| $284K | ﹤0.01% |
14,527
+1,936
| +15% | +$36.3K |
|
3569
Argan
AGX
$8.11B
| $283K | ﹤0.01% |
6,752
-2,302
| -25% | -$101K |
|
3570
CALL
Duke Energy
DUK
$96.6B
| $283K | ﹤0.01% |
3,200
-1,200
| -27% | -$98.9K |
|
3571
PUT
McKesson
MCK
$101B
| $283K | ﹤0.01% |
1,900
| – | – |
|
3572
PUT
Allstate
ALL
$66.1B
| $282K | ﹤0.01% |
3,000
| – | – |
|
3573
Newmark Group
NMRK
$2.76B
| $282K | ﹤0.01% |
65,409
-16,558
| -20% | -$71.6K |
|
|
TVRD
3574
Tvardi Therapeutics
TVRD
$23.7M
| $282K | ﹤0.01% |
614
-257
| -30% | -$149K |
|
|
PRTK
3575
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $281K | ﹤0.01% |
52,018
-2,528
| -5% | -$12.5K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.